Shares of Globe Life (GL.US), an S&P500-listed insurance company, fell more than 54% on Thursday, closing at their lowest level in eight years following a report on short-selling firm Fuzzy Panda Research. You can find detailed information about the above report here.
Fuzzy Panda claimed to have "uncovered extensive allegations of insurance fraud ignored by management." What's more, the report came after well-known short-game investor Nate Koppikar of Orso Partners called Globe Life a short-trade idea at the Sohn Investment Conference, held in New York last week.
Start investing today or test a free demo
Create account Try a demo Download mobile app Download mobile app"We reviewed the report and found it to be very misleading, mixing anonymous allegations with recycled points pushed by law firms to force Globe Life to settle," the - The company said in a statement. Ahead of the opening of today's trading session, Globe shares rebounded 5.5% on the company's assurances. The scale of the rebound, however, was clearly limited, as pre-session gains reached as high as 20% today.
The company's shares are currently trading at levels not seen since February 2016. Source: xStation
This content has been created by XTB S.A. This service is provided by XTB S.A., with its registered office in Warsaw, at Prosta 67, 00-838 Warsaw, Poland, entered in the register of entrepreneurs of the National Court Register (Krajowy Rejestr Sądowy) conducted by District Court for the Capital City of Warsaw, XII Commercial Division of the National Court Register under KRS number 0000217580, REGON number 015803782 and Tax Identification Number (NIP) 527-24-43-955, with the fully paid up share capital in the amount of PLN 5.869.181,75. XTB S.A. conducts brokerage activities on the basis of the license granted by Polish Securities and Exchange Commission on 8th November 2005 No. DDM-M-4021-57-1/2005 and is supervised by Polish Supervision Authority.
